News

Jazz Pharmaceuticals plc announced along with its partner PharmaMar that the U.S. Food and Drug Administration (FDA) approved Zepzelca (lurbinectedin) for the treatment of adult…
Read More...

Merck, known as MSD outside the United States and Canada, and Pfizer Inc. announced the presentation of results from the Phase 3 VERTIS CV cardiovascular (CV) outcomes trial that…
Read More...

IDEAYA Biosciences, Inc. and GlaxoSmithKline plc (GSK) announce a strategic partnership in Synthetic Lethality, an emerging field in Oncology. The strategic partnership includes…
Read More...

Sanofi detailed plans on how the Company will make significant investments in France to increase its vaccines research and production capacities, and contribute in responding to future…
Read More...

Monopar Therapeutics Inc. and NorthStar Medical Radioisotopes, LLC (Beloit, WI) announced a 50/50 collaboration to develop potential Radio-Immuno-Therapeutics (RITs) to treat severe…
Read More...

Eli Lilly and Company announced that the first patient has been enrolled in a Phase 3 randomized, double-blind, placebo–controlled study to evaluate the efficacy and safety of…
Read More...

ATUM and Phylex BioSciences have entered into a collaboration to leverage ATUM's Leap-In Transposase platform to develop the cell line essential to the manufacturing of Phylex's…
Read More...

Magenta Therapeutics and Beam Therapeutics announced a non-exclusive research and clinical collaboration agreement to evaluate the potential utility of MGTA-117, Magenta’s novel…
Read More...

The German Federal Minister for Economic Affairs and Energy, Peter Altmaier, and Dietmar Hopp, SAP co-founder and co-founder of the investment company dievini Hopp BioTech holding GmbH…
Read More...

MedRhythms, a Portland, Maine-based digital therapeutics company that is building direct stimulation, prescription digital therapeutics that use sensors, music, and software to improve…
Read More...

AstraZeneca has reached an agreement with Europe’s Inclusive Vaccines Alliance (IVA), spearheaded by Germany, France, Italy and the Netherlands, to supply up to 400 million doses of the…
Read More...

The U.S. Food and Drug Administration approved Tivicay (dolutegravir) tablets and Tivicay PD (dolutegravir) tablets for suspension to treat HIV-1 infection in pediatric patients at…
Read More...

Daiichi Sankyo Company, Limited announced its decision to develop a genetic (mRNA) vaccine for the novel corona virus infection (hereinafter, COVID-19) in Japan. In April, 2020,…
Read More...

Swedish Orphan Biovitrum AB and Selecta Biosciences, Inc. announced that the companies have entered into a strategic licensing agreement for the product candidate SEL-212. SEL-212 is a…
Read More...

Sofinnova Partners, a leading European life sciences venture capital firm based in Paris, London and Milan, announced the sale of its portfolio company Corvidia Therapeutics to Novo…
Read More...

Eli Lilly and Company announced its partner Junshi Biosciences has dosed the first healthy volunteer in a study of a potential neutralizing antibody treatment designed to fight…
Read More...

The European Investment Bank (EIB) and BioNTech SE concluded a €100 million debt financing agreement to support the development of BNT162, the company’s COVID-19 vaccine programme. The…
Read More...

Clovis Oncology, Inc. announced the completion of target patient enrollment in the Clovis-sponsored Phase 3 ATHENA trial evaluating the combination of Clovis’ Rubraca (rucaparib), a…
Read More...

Grifols announced the start of production of its anti-SARS-CoV-2 hyperimmune immunoglobulin with specific antibodies using the plasma of people who have overcome the disease. It is the…
Read More...

Takeda Pharmaceutical Company Limited announced that it has entered into an agreement to divest a portfolio of select non-core over-the-counter (OTC) and prescription pharmaceutical…
Read More...